SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-041725
Filing Date
2021-08-05
Accepted
2021-08-05 17:17:08
Documents
57
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q avro-10q_20210630.htm   iXBRL 10-Q 2240896
2 EX-31.1 avro-ex311_13.htm EX-31.1 17721
3 EX-31.2 avro-ex312_12.htm EX-31.2 17793
4 EX-32.1 avro-ex321_14.htm EX-32.1 10856
  Complete submission text file 0001564590-21-041725.txt   6091652

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA avro-20210630.xsd EX-101.SCH 38009
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE avro-20210630_cal.xml EX-101.CAL 29138
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE avro-20210630_def.xml EX-101.DEF 96336
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE avro-20210630_lab.xml EX-101.LAB 292961
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avro-20210630_pre.xml EX-101.PRE 211463
10 EXTRACTED XBRL INSTANCE DOCUMENT avro-10q_20210630_htm.xml XML 915554
Mailing Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139 7819626030
AVROBIO, Inc. (Filer) CIK: 0001681087 (see all company filings)

IRS No.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38537 | Film No.: 211149509
SIC: 2836 Biological Products, (No Diagnostic Substances)